Skip to main content Skip to Footer


February 26, 2014
Just how ready are life sciences companies to manage risk? (3 of 6)
By: Anne O'Riordan

There’s a measurable gap between the maturity of life sciences companies’ current risk management capabilities and their perceived future need for these capabilities—this, one of the most notable findings from the Accenture 2013 Global Risk Management Study.

But there is still room for improvement in managing risk

What these findings reveal is that life sciences companies still have room for improvement in managing risk, but it’s not all doom and gloom. As I’ll share next week, many life sciences companies are confident in their ability to address critical risks facing the industry.

To learn more:

More blogs on this topic